MV-NiV

CEPI-Nipah

at a glance

TARGET DISEASE

Nipah virus Infection

TIMELINE

01 March 2019 to 28 February 2024

COORDINATOR

University of Tokyo with European Vaccine Initiative as co-leader

FUNDER

CEPI

FUNDING

10 Mio US$

SUMMARY

CEPI-Nipah

​

https://cepi.net/news_cepi/cepi-awards-contract-worth-up-to-us-31-million-to-the-university-of-tokyo-to-develop-vaccine-against-nipah-virus/

PARTNERS

Batavia Biosciences (Netherlands); European Vaccine Initiative (EVI) (Germany); University of Stanford (USA); University of Tokyo (Japan).

Partners List

​

​

​

​

​